Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company's robust financial performance, with significant revenue and profit growth, coupled with strategic AI integration and expansion in insurance and healthcare sectors, presents a positive outlook. Despite increased operational costs and potential risks, the optimistic guidance and strong shareholder return plan, including dividends and share repurchases, bolster investor confidence. The strong revenue growth and AI-driven innovations suggest potential upside in stock price, with a positive sentiment prevailing over the next two weeks.
Revenue for fiscal year 2025 RMB 3.98 billion, up 43.5% year-over-year. The increase was attributed to the execution of the AI plus insurance strategy and business growth.
Net profit attributable to ordinary shareholders for fiscal year 2025 RMB 570 million, up 64.8% year-over-year. This growth was due to strong performance and operational efficiency.
Insurance-related income for fiscal year 2025 RMB 3.58 billion, up 51.3% year-over-year. The growth was driven by strong momentum in the insurance business.
Insurance-related income for Q4 2025 RMB 1.31 billion, up 125% year-over-year. The increase was due to improved user identification and AI-driven enhancements.
Operating profit for insurance business in Q4 2025 RMB 160 million, up 42% year-over-year. This was supported by AI integration and product innovations.
Quarterly revenue for Q4 2025 RMB 1.41 billion, up 105.5% year-over-year. The growth was attributed to accelerated business performance.
Operating costs for Q4 2025 RMB 680 million, up 109.2% year-over-year. The increase was driven by higher referral and service fees and SMS costs.
Sales and marketing expenses for Q4 2025 RMB 510 million, up 178.4% year-over-year. The rise was due to increased investments in customer acquisition and third-party traffic channels.
G&A expenses for Q4 2025 RMB 77.1 million, up 4.6% year-over-year. The increase was mainly due to higher allowances for party losses and professional services.
R&D expenses for Q4 2025 RMB 66.2 million, up 21.9% year-over-year. The rise was driven by increased personnel costs and cloud services.
Net profit attributable to ordinary shareholders for Q4 2025 RMB 162 million, up 62.7% year-over-year. This was due to improved profitability and operational efficiency.
Cash position as of end of 2025 RMB 3.25 billion. This provides strong support for future growth.
AI Pro Insurance Engine: Drove a 33% sequential increase in premium and generated over RMB 50 million in FIP, marking a 145% quarter-over-quarter growth.
Zero Deductible Insurance (Version 2.0): Covers both projected long-term medical costs and routine medical expenses, gaining strong traction.
Pre-existing Condition Product: Achieved FIP at nearly 70%, validating its long-term strategy.
Disability Insurance: Contributed about RMB 100 million in FIP.
Waterdrop Sea.AI: Unified AI capabilities across workflows, enabling scenario-specific agents and opened to industry partners.
Xiao Bao AI Planner: Deployed across WeChat platforms for product recommendations, business facilitation, and user-agent matching.
Insurance Business Growth: Insurance-related income surged 125% year-on-year to RMB 1.31 billion, with operating profit growing 42% year-over-year to RMB 160 million.
Digital Clinical Trial Solutions: Revenue related to chronic diseases grew by 30% this quarter compared to the previous three quarters' average.
E-Find Platform: Partnered with 224 pharmaceutical companies, enrolling 14,055 cumulative patients and initiating 131 new programs.
AI Integration: Deployed multi-modal AI agents across workflows, achieving measurable operating gains and enhancing customer service efficiency by 2.75 times.
Data Privacy and Risk Control: Upgraded systems with large language models for dynamic data masking and deployed a medical knowledge graph for content authenticity.
Patient Matching Technology: Achieved a national invention patent for precision matching technology, reducing manual screening workloads significantly.
AI-Native Company Transition: Accelerating shift to become an AI-native company, embedding AI as a structural competitive advantage.
ESG Initiatives: Collaborated with 119 organizations on 15,500 projects, earning an A+ ESG rating.
Shareholder Returns: Approved a fifth cash dividend of $0.03 per ADS, totaling $10.8 million, and repurchased 60.7 million ADS for $118 million.
Market Conditions: Potential risks and uncertainties were mentioned in relation to forward-looking statements, which could cause actual results to differ materially from expectations.
Regulatory Compliance: The company highlighted risks related to compliance with regulations, particularly in the context of forward-looking statements and public filings with the SEC.
Operational Costs: Operating costs and expenses increased significantly year-on-year, driven by higher referral and service fees, SMS costs, and marketing expenses for third-party traffic channels.
Customer Acquisition Costs: Sales and marketing expenses rose significantly, with a notable increase in marketing expenses for third-party traffic channels, which could impact profitability if not managed effectively.
Data Privacy and Security: The company emphasized the importance of protecting user privacy and preventing information theft, highlighting risks related to sensitive data handling and system upgrades.
Strategic Execution: The company plans moderately higher investments in marketing and AI, which could pose risks if these investments do not yield the expected double-digit growth in revenue and profit.
Revenue and Profit Growth: The company aims to sustain momentum in 2026 with moderately higher investments in marketing and AI, targeting double-digit growth in both revenue and profit.
AI Integration and Development: Waterdrop plans to become a truly AI-enabled company by visually reconstructing its entire value chain and embedding AI as a structural competitive advantage. The company is accelerating its shift to an AI-native model, with 72 LLM-related patent applications filed by the end of 2025.
Insurance Business Expansion: The insurance segment is expected to continue its strong momentum, with AI embedded in every node of the service chain. New product features, such as zero-deductible options and pre-existing condition coverage, are gaining traction.
Healthcare Business Growth: The E-Find platform is expanding, with a focus on complex and rare cancer cases. The company aims to grow its patient base and revenue from digital clinical trials, particularly in chronic diseases.
Cash Dividend: The Board approved the fifth cash dividend of $0.03 per ADS, totaling $10.8 million. This will be paid in late April to early May to shareholders of record as of April 24, 2026, U.S. ET time.
Share Repurchase Program: The share repurchase program remains on track, with 60.7 million ADS repurchased for approximately $118 million by the end of 2026.
The company's robust financial performance, with significant revenue and profit growth, coupled with strategic AI integration and expansion in insurance and healthcare sectors, presents a positive outlook. Despite increased operational costs and potential risks, the optimistic guidance and strong shareholder return plan, including dividends and share repurchases, bolster investor confidence. The strong revenue growth and AI-driven innovations suggest potential upside in stock price, with a positive sentiment prevailing over the next two weeks.
The company reported strong financial performance with significant revenue and net profit growth, driven by AI integration and business expansion. Despite increased operating costs, profitability improved, supported by shareholder returns through dividends and share repurchases. However, risks include rising expenses and regulatory uncertainties, but optimistic guidance and strategic AI investments suggest positive sentiment. The absence of any negative sentiment from the Q&A further supports a positive outlook.
The company reported strong financial performance with significant revenue and profit growth, driven by AI integration. Enhanced shareholder returns through increased dividends and share repurchases are positive signals. Despite potential risks like regulatory hurdles and economic uncertainties, the optimistic guidance and operational efficiency improvements outweigh concerns. The sentiment from the Q&A section did not provide additional negative insights to alter the positive outlook.
The earnings call highlights strong financial performance, including a significant increase in net profit and stable operating margins. The company is expanding AI investments and partnerships, which are positive for future growth. Shareholder returns through dividends and share repurchases further boost sentiment. Despite some regulatory and competitive risks, the overall outlook remains positive with strategic investments and a solid cash position supporting growth. The absence of significant concerns in the Q&A session reinforces this sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.